使用Olezarsen针对中度高甘油三血症
Brian A Bergmark1,2, Nicholas A Marston1,2, Thomas A Prohaska3
1TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston.
The New England journal of medicine
|September 1, 2025
概括
在中度高甘油血症和心血管风险升高的患者中,Olezarsen显著降低了甘油三水平. 这种新的抗意义寡核酸疗法为控制高甘油水平提供了一个有前途的新选择.
科学领域:
- 心血管医学
- 药理学
- 遗传学
背景情况:
- 有限有效的治疗方法可以降低甘油三水平.
- 奥莱萨森是一种针对阿波利波蛋白C-IIImRNA的反感性寡核酸,这是三糖清除的关键抑制剂.
研究的目的:
- 评估Olezarsen在中度或重度高甘油脂血症患者的疗效和安全性.
- 评估6个月后调整的甘油三水平的变化.
主要方法:
- 第三阶段,国际双盲,随机,安慰剂对照试验.
- 有1349名中度或重度高糖血症患者每月接受皮下注射Olezarsen (50mg或80mg) 或安慰剂.
- 从基线到6个月的三糖化物水平中最小方位平均百分比变化.
主要成果:
- 与安慰剂相比,Olezarsen显著降低了甘油三水平.
- 50毫克剂量显示了与安慰剂调整后的-58. 4个百分点的降低 (P< 0. 001).
- 80毫克剂量显示了与安慰剂调整后的-60. 6个百分点的减少 (P< 0. 001).
结论:
- 在中度高甘油血症和心血管风险升高的患者中,Olezarsen治疗导致甘油三水平显著降低.
- 在治疗组中,严重不良事件的发生率相似.
- Olezarsen 是一种有前途的治疗方案,用于治疗高甘油三.
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
255
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
255
Lipid Absorption
708
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
708
Lipid Digestion
93.8K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
93.8K
Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145


